Timothy D. Lyon, MD, discuss logistical and clinical challenges faced by patients with non–muscle-invasive bladder cancer who undergo intravesical therapy.
Timothy D. Lyon, MD
Advertisement
Timothy D. Lyon, MD is an Associate Professor of Urology and the Urology Residency Program Director at Mayo Clinic in Jacksonville, Florida.
Articles by Timothy D. Lyon, MD
Advertisement
Latest Updated Articles
Dr Lyon on Logistical and Clinical Challenges Associated With Intravesical Therapy for NMIBCPublished: December 5th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
4
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
5